ERBB2 and breast carcinoma: Interestingly, the different breast cancer intrinsic subtypes (i.e., luminal A and B, HER2‐enriched, and basal‐like) have distinct preferred metastatic sites [7], and both the tumor cell and the metastatic microenvironment might contribute to this organ specificity [8].